286 related articles for article (PubMed ID: 30194536)
1. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
[TBL] [Abstract][Full Text] [Related]
2. Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of
Scalese G; Machado I; Salinas G; Pérez-Díaz L; Gambino D
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500808
[TBL] [Abstract][Full Text] [Related]
3. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
[TBL] [Abstract][Full Text] [Related]
4. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents.
Fernández M; Becco L; Correia I; Benítez J; Piro OE; Echeverria GA; Medeiros A; Comini M; Lavaggi ML; González M; Cerecetto H; Moreno V; Pessoa JC; Garat B; Gambino D
J Inorg Biochem; 2013 Oct; 127():150-60. PubMed ID: 23528424
[TBL] [Abstract][Full Text] [Related]
5. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
[TBL] [Abstract][Full Text] [Related]
6. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
7. Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.
Benítez J; Guggeri L; Tomaz I; Arrambide G; Navarro M; Pessoa JC; Garat B; Gambino D
J Inorg Biochem; 2009 Apr; 103(4):609-16. PubMed ID: 19091422
[TBL] [Abstract][Full Text] [Related]
8. Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
Scalese G; Mosquillo MF; Rostán S; Castiglioni J; Alho I; Pérez L; Correia I; Marques F; Costa Pessoa J; Gambino D
J Inorg Biochem; 2017 Oct; 175():154-166. PubMed ID: 28755573
[TBL] [Abstract][Full Text] [Related]
9. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
11. Development of new dinuclear Fe(III) coordination compounds with
Moreira FF; Portes JA; Barros Azeredo NF; Fernandes C; Horn A; Santiago CP; Segat BB; Caramori GF; Madureira LMP; Candela DRS; Marques MM; Lamounier Camargos Resende JA; de Souza W; DaMatta RA; Seabra SH
Dalton Trans; 2021 Sep; 50(35):12242-12264. PubMed ID: 34519725
[TBL] [Abstract][Full Text] [Related]
12. Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: Synthesis, characterization and activity against Trypanosoma cruzi.
Rodríguez Arce E; Machado I; Rodríguez B; Lapier M; Zúñiga MC; Maya JD; Olea Azar C; Otero L; Gambino D
J Inorg Biochem; 2017 May; 170():125-133. PubMed ID: 28237731
[TBL] [Abstract][Full Text] [Related]
13. Effect of Fluorination on the Structure and Anti-
Salsi F; Bulhões Portapilla G; Simon S; Roca Jungfer M; Hagenbach A; de Albuquerque S; Abram U
Inorg Chem; 2019 Aug; 58(15):10129-10138. PubMed ID: 31310108
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
17. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
[TBL] [Abstract][Full Text] [Related]
18. Trypanocidal and leishmanicidal activities of flavonoids isolated from Stevia satureiifolia var. satureiifolia.
Beer MF; Frank FM; Germán Elso O; Ernesto Bivona A; Cerny N; Giberti G; Luis Malchiodi E; Susana Martino V; Alonso MR; Patricia Sülsen V; Cazorla SI
Pharm Biol; 2016 Oct; 54(10):2188-95. PubMed ID: 26983579
[TBL] [Abstract][Full Text] [Related]
19. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
20. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
